suPAR data from Acute Care published in Emergency Medicine Journal

Mon Jan 23 2017

The article “suPAR in Acute Care: A strong marker of disease presence and severity, readmission and mortality. A retrospective cohort study” was recently published in Emergency Medicine Journal.

The study included 4343 consecutively admitted patients from the AMU at a large Danish university hospital (Hvidovre).

The conclusion is again, that in an unselected population of acute medical patients;
“A high suPAR level upon admission to the AMU is a marker of severe disease and increased risk of readmission and mortality after adjusting for all other risk factors …. and suPAR adds information to established prognostic indicators”.

Patients with low suPAR levels have low risk of readmission and mortality, while patients with high suPAR levels have a high risk of adverse events.

Please find the publication
by Line J.H.Rasmussen et al from EMJ here

2016_Rasmussen_et_al_suPAR_in_acute_care_-_A_strong_marker_of_disease_presence_and_severity_readmission_and_mortality._A_retrospective_cohort_study

+700

published suPAR studies in leading medical journals

The suPARnostic® brand consists of 3 products:

Photo of The suPARnostic® Quick Triage kit

Quick Triage

A Point of Care Solution

Photo of suPARnostic® TurbiLatex

TurbiLatex

For Automated Systems

Photo of suPARnostic® ELISA

ELISA Assay

Clinical and Research

Would you like to know more?

If you have any questions regarding our products or business, write to us here

Thank you!

You'll hear from us shortly.

An error occured!

Please try again, or contact us by e-mail if the problem persist.

Sign up for our newsletter

By signing up for our newsletter you will receive the latest news about our products.

Thank you!

You'll hear from us shortly.

An error occured!

Please try again, or contact us by e-mail if the problem persist.

New Webinar

Webinar

Catch COVID-19

-Improve your triage

Sign up to view webinar recording

View recording

suPARnostic® by ViroGates